Department of Biomedicine and Prevention, Unit of Vascular Surgery, University of Rome 'Tor Vergata', Viale Oxford 81, 00133 Rome, Italy.
Eur J Vasc Endovasc Surg. 2013 Jun;45(6):607-9. doi: 10.1016/j.ejvs.2013.02.017. Epub 2013 Mar 27.
The aim of this report was to analyse early and mid-term outcomes of endovascular treatment (endovascular aneurysm repair, EVAR) for aorto-iliac aneurysms with the use of an iliac branch device (IBD).
A total of 85 EVAR procedures with IBD were electively carried out in 81 patients between September 2007 and August 2012. Technical success was obtained in 98.7% of the cases. The mean follow-up duration was 20.4 months (SD ± 15.4). There was one IBD occlusion (1.2%). Estimated 48 months' survival, freedom from re-intervention and branch occlusion were 76.7%, 88.3% and 98%, respectively.
EVAR for aorto-iliac aneurysms using IBD is an effective procedure with low complication and re-intervention rates at mid-term follow-up.
本报告旨在分析使用髂分支装置（iliac branch device，IBD）进行腹主动脉-髂动脉瘤腔内治疗（endovascular aneurysm repair，EVAR）的早期和中期结果。
2007 年 9 月至 2012 年 8 月期间，81 例患者共进行了 85 例选择性 EVAR 手术和 IBD。术中技术成功率为 98.7%。平均随访时间为 20.4 个月（SD ± 15.4）。有 1 例 IBD 闭塞（1.2%）。估计 48 个月的生存率、免于再次干预和分支闭塞率分别为 76.7%、88.3%和 98%。
使用 IBD 进行腹主动脉-髂动脉瘤的 EVAR 是一种有效的治疗方法，中期随访结果显示并发症和再次干预率较低。
